Ibrutinib-related hypertension associated with increased risk for major adverse cardiovascular events.
Background: Cachexia affects nearly 50–80% of cancer patients, and most studies have only focused on elderly patients. We investigated preoperative cachexia in gastric cancer (GC) patients by age group and comprehensively analyzed the impact of preoperative cachexia on the prognosis of GC patients in all age groups.Methods: In total, 575 patients were prospectively analyzed. The effect of…
Researchers found a low incidence of thrombotic events in patients receiving ibrutinib, though some patients still experienced bleeding.
The guideline includes strategies to identify patients with nonmetastatic cancer who may be at a higher risk for osteoporotic fractures
[Cancer Management and Research] Researchers sought an alternative regimen for urine alkalization in patients receiving high-dose methotrexate. The typical regimen, IV sodium bicarbonate, has been on shortage. This study determined the safety of an oral regimen of sodium bicarbonate and acetazolamide to achieve a urine pH >7, which is necessary for safe administration of high-dose methotrexate.
A review of what researchers are finding about “chemobrain,” a common adverse effect experienced by patients receiving chemotherapy for cancer.
Novel treatment of insomnia helped almost half of the study population achieve remission of their insomnia after Step 1, with almost 80% of the remaining patients achieving remission of their insomnia after Step 2.
A literature review identified CIPN as a potential contributor to falls and injuries in patients with cancer; however, evidence-based methods for preventing falls in these patients are scarce.
A substudy of the PACIFIC trial sought to determine if low-grade pneumonitis associated with durvalumab should deter its use in patients with NSCLC.
Using a subset from the GeparOcto trial, researchers sought to determine if IV FCM was superior to physicians’ choice in treating chemotherapy-induced anemia in patients with breast cancer.